Biopharmaceutical Analytical Testing Services - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511248410

Publication Date:

November 27, 2024

Pages:

105

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Biopharmaceutical Analytical Testing Services is a workflow for identifying and quantifying host cell protein-related impurities in pharmaceutical products, separate therapeutic and diagnostic oligonucleotides and their derivatives, and validated structural protein comparative analysis for biosimilar development the process of.
The global market for Biopharmaceutical Analytical Testing Services was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical Analytical Testing Services, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Biopharmaceutical Analytical Testing Services by region & country, by Type, and by Application.
The Biopharmaceutical Analytical Testing Services market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical Analytical Testing Services.
麻豆原创 Segmentation
By Company
Boston Analytical
Catalent Inc.
Charles River Laboratories International Inc.
Eurofins Scientific
Intertek Group
Merck KGaA
SGS SA
Solvias AG
STERIS
West Pharmaceutical Services Inc.
Segment by Type:
Test Suite
Testing Services
Testing Software
Other
Segment by Application
Laboratory
Research Institutions
Pharmaceutical Center
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Biopharmaceutical Analytical Testing Services manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Biopharmaceutical Analytical Testing Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Biopharmaceutical Analytical Testing Services in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Biopharmaceutical Analytical Testing Services Product Introduction
1.2 Global Biopharmaceutical Analytical Testing Services 麻豆原创 Size Forecast
1.3 Biopharmaceutical Analytical Testing Services 麻豆原创 Trends & Drivers
1.3.1 Biopharmaceutical Analytical Testing Services Industry Trends
1.3.2 Biopharmaceutical Analytical Testing Services 麻豆原创 Drivers & Opportunity
1.3.3 Biopharmaceutical Analytical Testing Services 麻豆原创 Challenges
1.3.4 Biopharmaceutical Analytical Testing Services 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Biopharmaceutical Analytical Testing Services Players Revenue Ranking (2023)
2.2 Global Biopharmaceutical Analytical Testing Services Revenue by Company (2019-2024)
2.3 Key Companies Biopharmaceutical Analytical Testing Services Manufacturing Base Distribution and Headquarters
2.4 Key Companies Biopharmaceutical Analytical Testing Services Product Offered
2.5 Key Companies Time to Begin Mass Production of Biopharmaceutical Analytical Testing Services
2.6 Biopharmaceutical Analytical Testing Services 麻豆原创 Competitive Analysis
2.6.1 Biopharmaceutical Analytical Testing Services 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Biopharmaceutical Analytical Testing Services Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Analytical Testing Services as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Test Suite
3.1.2 Testing Services
3.1.3 Testing Software
3.1.4 Other
3.2 Global Biopharmaceutical Analytical Testing Services Sales Value by Type
3.2.1 Global Biopharmaceutical Analytical Testing Services Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Biopharmaceutical Analytical Testing Services Sales Value, by Type (2019-2030)
3.2.3 Global Biopharmaceutical Analytical Testing Services Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Laboratory
4.1.2 Research Institutions
4.1.3 Pharmaceutical Center
4.1.4 Other
4.2 Global Biopharmaceutical Analytical Testing Services Sales Value by Application
4.2.1 Global Biopharmaceutical Analytical Testing Services Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Biopharmaceutical Analytical Testing Services Sales Value, by Application (2019-2030)
4.2.3 Global Biopharmaceutical Analytical Testing Services Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Biopharmaceutical Analytical Testing Services Sales Value by Region
5.1.1 Global Biopharmaceutical Analytical Testing Services Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Biopharmaceutical Analytical Testing Services Sales Value by Region (2019-2024)
5.1.3 Global Biopharmaceutical Analytical Testing Services Sales Value by Region (2025-2030)
5.1.4 Global Biopharmaceutical Analytical Testing Services Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Biopharmaceutical Analytical Testing Services Sales Value, 2019-2030
5.2.2 North America Biopharmaceutical Analytical Testing Services Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Biopharmaceutical Analytical Testing Services Sales Value, 2019-2030
5.3.2 Europe Biopharmaceutical Analytical Testing Services Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Biopharmaceutical Analytical Testing Services Sales Value, 2019-2030
5.4.2 Asia Pacific Biopharmaceutical Analytical Testing Services Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Biopharmaceutical Analytical Testing Services Sales Value, 2019-2030
5.5.2 South America Biopharmaceutical Analytical Testing Services Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Biopharmaceutical Analytical Testing Services Sales Value, 2019-2030
5.6.2 Middle East & Africa Biopharmaceutical Analytical Testing Services Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Biopharmaceutical Analytical Testing Services Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Biopharmaceutical Analytical Testing Services Sales Value
6.3 United States
6.3.1 United States Biopharmaceutical Analytical Testing Services Sales Value, 2019-2030
6.3.2 United States Biopharmaceutical Analytical Testing Services Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Biopharmaceutical Analytical Testing Services Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Biopharmaceutical Analytical Testing Services Sales Value, 2019-2030
6.4.2 Europe Biopharmaceutical Analytical Testing Services Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Biopharmaceutical Analytical Testing Services Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Biopharmaceutical Analytical Testing Services Sales Value, 2019-2030
6.5.2 China Biopharmaceutical Analytical Testing Services Sales Value by Type (%), 2023 VS 2030
6.5.3 China Biopharmaceutical Analytical Testing Services Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Biopharmaceutical Analytical Testing Services Sales Value, 2019-2030
6.6.2 Japan Biopharmaceutical Analytical Testing Services Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Biopharmaceutical Analytical Testing Services Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Biopharmaceutical Analytical Testing Services Sales Value, 2019-2030
6.7.2 South Korea Biopharmaceutical Analytical Testing Services Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Biopharmaceutical Analytical Testing Services Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Biopharmaceutical Analytical Testing Services Sales Value, 2019-2030
6.8.2 Southeast Asia Biopharmaceutical Analytical Testing Services Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Biopharmaceutical Analytical Testing Services Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Biopharmaceutical Analytical Testing Services Sales Value, 2019-2030
6.9.2 India Biopharmaceutical Analytical Testing Services Sales Value by Type (%), 2023 VS 2030
6.9.3 India Biopharmaceutical Analytical Testing Services Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Boston Analytical
7.1.1 Boston Analytical Profile
7.1.2 Boston Analytical Main Business
7.1.3 Boston Analytical Biopharmaceutical Analytical Testing Services Products, Services and Solutions
7.1.4 Boston Analytical Biopharmaceutical Analytical Testing Services Revenue (US$ Million) & (2019-2024)
7.1.5 Boston Analytical Recent Developments
7.2 Catalent Inc.
7.2.1 Catalent Inc. Profile
7.2.2 Catalent Inc. Main Business
7.2.3 Catalent Inc. Biopharmaceutical Analytical Testing Services Products, Services and Solutions
7.2.4 Catalent Inc. Biopharmaceutical Analytical Testing Services Revenue (US$ Million) & (2019-2024)
7.2.5 Catalent Inc. Recent Developments
7.3 Charles River Laboratories International Inc.
7.3.1 Charles River Laboratories International Inc. Profile
7.3.2 Charles River Laboratories International Inc. Main Business
7.3.3 Charles River Laboratories International Inc. Biopharmaceutical Analytical Testing Services Products, Services and Solutions
7.3.4 Charles River Laboratories International Inc. Biopharmaceutical Analytical Testing Services Revenue (US$ Million) & (2019-2024)
7.3.5 Eurofins Scientific Recent Developments
7.4 Eurofins Scientific
7.4.1 Eurofins Scientific Profile
7.4.2 Eurofins Scientific Main Business
7.4.3 Eurofins Scientific Biopharmaceutical Analytical Testing Services Products, Services and Solutions
7.4.4 Eurofins Scientific Biopharmaceutical Analytical Testing Services Revenue (US$ Million) & (2019-2024)
7.4.5 Eurofins Scientific Recent Developments
7.5 Intertek Group
7.5.1 Intertek Group Profile
7.5.2 Intertek Group Main Business
7.5.3 Intertek Group Biopharmaceutical Analytical Testing Services Products, Services and Solutions
7.5.4 Intertek Group Biopharmaceutical Analytical Testing Services Revenue (US$ Million) & (2019-2024)
7.5.5 Intertek Group Recent Developments
7.6 Merck KGaA
7.6.1 Merck KGaA Profile
7.6.2 Merck KGaA Main Business
7.6.3 Merck KGaA Biopharmaceutical Analytical Testing Services Products, Services and Solutions
7.6.4 Merck KGaA Biopharmaceutical Analytical Testing Services Revenue (US$ Million) & (2019-2024)
7.6.5 Merck KGaA Recent Developments
7.7 SGS SA
7.7.1 SGS SA Profile
7.7.2 SGS SA Main Business
7.7.3 SGS SA Biopharmaceutical Analytical Testing Services Products, Services and Solutions
7.7.4 SGS SA Biopharmaceutical Analytical Testing Services Revenue (US$ Million) & (2019-2024)
7.7.5 SGS SA Recent Developments
7.8 Solvias AG
7.8.1 Solvias AG Profile
7.8.2 Solvias AG Main Business
7.8.3 Solvias AG Biopharmaceutical Analytical Testing Services Products, Services and Solutions
7.8.4 Solvias AG Biopharmaceutical Analytical Testing Services Revenue (US$ Million) & (2019-2024)
7.8.5 Solvias AG Recent Developments
7.9 STERIS
7.9.1 STERIS Profile
7.9.2 STERIS Main Business
7.9.3 STERIS Biopharmaceutical Analytical Testing Services Products, Services and Solutions
7.9.4 STERIS Biopharmaceutical Analytical Testing Services Revenue (US$ Million) & (2019-2024)
7.9.5 STERIS Recent Developments
7.10 West Pharmaceutical Services Inc.
7.10.1 West Pharmaceutical Services Inc. Profile
7.10.2 West Pharmaceutical Services Inc. Main Business
7.10.3 West Pharmaceutical Services Inc. Biopharmaceutical Analytical Testing Services Products, Services and Solutions
7.10.4 West Pharmaceutical Services Inc. Biopharmaceutical Analytical Testing Services Revenue (US$ Million) & (2019-2024)
7.10.5 West Pharmaceutical Services Inc. Recent Developments
8 Industry Chain Analysis
8.1 Biopharmaceutical Analytical Testing Services Industrial Chain
8.2 Biopharmaceutical Analytical Testing Services Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Biopharmaceutical Analytical Testing Services Sales Model
8.5.2 Sales Channel
8.5.3 Biopharmaceutical Analytical Testing Services Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Boston Analytical
Catalent Inc.
Charles River Laboratories International Inc.
Eurofins Scientific
Intertek Group
Merck KGaA
SGS SA
Solvias AG
STERIS
West Pharmaceutical Services Inc.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.